Correlation Between Pharvaris and Adagene

Specify exactly 2 symbols:
Can any of the company-specific risk be diversified away by investing in both Pharvaris and Adagene at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Pharvaris and Adagene into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Pharvaris BV and Adagene, you can compare the effects of market volatilities on Pharvaris and Adagene and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Pharvaris with a short position of Adagene. Check out your portfolio center. Please also check ongoing floating volatility patterns of Pharvaris and Adagene.

Diversification Opportunities for Pharvaris and Adagene

PharvarisAdageneDiversified AwayPharvarisAdageneDiversified Away100%
0.56
  Correlation Coefficient

Very weak diversification

The 3 months correlation between Pharvaris and Adagene is 0.56. Overlapping area represents the amount of risk that can be diversified away by holding Pharvaris BV and Adagene in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Adagene and Pharvaris is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Pharvaris BV are associated (or correlated) with Adagene. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Adagene has no effect on the direction of Pharvaris i.e., Pharvaris and Adagene go up and down completely randomly.

Pair Corralation between Pharvaris and Adagene

Given the investment horizon of 90 days Pharvaris BV is expected to under-perform the Adagene. But the stock apears to be less risky and, when comparing its historical volatility, Pharvaris BV is 1.65 times less risky than Adagene. The stock trades about -0.32 of its potential returns per unit of risk. The Adagene is currently generating about 0.12 of returns per unit of risk over similar time horizon. If you would invest  185.00  in Adagene on November 30, 2024 and sell it today you would earn a total of  13.00  from holding Adagene or generate 7.03% return on investment over 90 days.
Time Period3 Months [change]
DirectionMoves Together 
StrengthWeak
Accuracy100.0%
ValuesDaily Returns

Pharvaris BV  vs.  Adagene

 Performance 
JavaScript chart by amCharts 3.21.15Dec2025Feb -20-10010
JavaScript chart by amCharts 3.21.15PHVS ADAG
       Timeline  
Pharvaris BV 

Risk-Adjusted Performance

Very Weak

 
Weak
 
Strong
Over the last 90 days Pharvaris BV has generated negative risk-adjusted returns adding no value to investors with long positions. In spite of weak performance in the last few months, the Stock's basic indicators remain comparatively stable which may send shares a bit higher in March 2025. The newest uproar may also be a sign of mid-term up-swing for the firm private investors.
JavaScript chart by amCharts 3.21.15DecJanFebJanFeb1618202224
Adagene 

Risk-Adjusted Performance

Very Weak

 
Weak
 
Strong
Over the last 90 days Adagene has generated negative risk-adjusted returns adding no value to investors with long positions. Despite nearly stable basic indicators, Adagene is not utilizing all of its potentials. The latest stock price disturbance, may contribute to mid-run losses for the stockholders.
JavaScript chart by amCharts 3.21.15DecJanFebJanFeb1.822.22.42.62.8

Pharvaris and Adagene Volatility Contrast

   Predicted Return Density   
JavaScript chart by amCharts 3.21.15-5.77-4.32-2.87-1.420.01.32.613.915.22 0.0150.0200.0250.0300.035
JavaScript chart by amCharts 3.21.15PHVS ADAG
       Returns  

Pair Trading with Pharvaris and Adagene

The main advantage of trading using opposite Pharvaris and Adagene positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Pharvaris position performs unexpectedly, Adagene can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Adagene will offset losses from the drop in Adagene's long position.
The idea behind Pharvaris BV and Adagene pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.
Check out your portfolio center.
Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Aroon Oscillator module to analyze current equity momentum using Aroon Oscillator and other momentum ratios.

Other Complementary Tools

Technical Analysis
Check basic technical indicators and analysis based on most latest market data
Headlines Timeline
Stay connected to all market stories and filter out noise. Drill down to analyze hype elasticity
Instant Ratings
Determine any equity ratings based on digital recommendations. Macroaxis instant equity ratings are based on combination of fundamental analysis and risk-adjusted market performance
Portfolio Comparator
Compare the composition, asset allocations and performance of any two portfolios in your account
AI Portfolio Architect
Use AI to generate optimal portfolios and find profitable investment opportunities